https://news.medxy.ai/zh/bevacizumab-vs-laser-rop/Medxy AIzh2026-10-10T04:22:04-07:00早产儿视网膜病变中玻璃体腔注射贝伐珠单抗与激光治疗的比较：再次治疗率、时机及风险预测因素分析 https://news.medxy.ai/ja/retinopathy-treatment-comparison/Medxy AIja2026-10-10T04:21:45-07:00未熟児網膜症に対する硝子体内ベバシズマブとレーザー治療の比較：再治療率、実施時期、およびリスク予測因子の解析 https://news.medxy.ai/vi/bevacizumab-vs-laser/Medxy AIvi2026-10-10T04:21:25-07:00Bevacizumab nội nhãn so với quang đông laser trong bệnh võng mạc trẻ đẻ non: phân tích tỷ lệ, thời điểm và yếu tố dự báo điều trị lại https://news.medxy.ai/intravitreal-bevacizumab-versus-laser-therapy-in-retinopathy-of-prematurity-analyzing-retreatment-rates-timing-and-risk-predictors/Medxy AIen2026-10-10T04:21:08-07:00Intravitreal Bevacizumab versus Laser Therapy in Retinopathy of Prematurity: Analyzing Retreatment Rates, Timing, and Risk Predictors https://news.medxy.ai/zh/bietti-retinopathy-3d-structure/Medxy AIzh2026-10-10T04:06:58-07:00揭示 Bietti 晶状体样营养不良中外层视网膜管状结构的复杂三维架构 https://news.medxy.ai/ja/bietti-retinopathy-architecture/Medxy AIja2026-10-10T04:06:42-07:00Bietti結晶様視網膜ジストロフィーにおける外網膜管状構造の三次元アーキテクチャを解明する https://news.medxy.ai/vi/bietti-retinal-tubes/Medxy AIvi2026-10-10T04:06:20-07:00Giải mã kiến trúc ba chiều phức tạp của ống hóa võng mạc ngoài trong loạn dưỡng thể tinh thể Bietti https://news.medxy.ai/unraveling-the-complex-3d-architecture-of-outer-retinal-tubulation-in-bietti-crystalline-dystrophy/Medxy AIen2026-10-10T04:06:00-07:00Unraveling the Complex 3D Architecture of Outer Retinal Tubulation in Bietti Crystalline Dystrophy https://news.medxy.ai/zh/subglottic-stenosis-pregnancy/Medxy AIzh2026-10-10T04:05:23-07:00妊娠期特发性声门下狭窄：病例对照研究揭示安全性、临床过程与管理要点 https://news.medxy.ai/ja/laryngeal-stenosis-pregnancy/Medxy AIja2026-10-10T04:05:06-07:00妊娠中の特発性声門下狭窄症：症例対照研究が示す安全性、臨床経過、治療の要点 https://news.medxy.ai/vi/idiopathic-subglottic-stenosis-pregnancy/Medxy AIvi2026-10-10T04:04:44-07:00Hẹp dưới thanh môn vô căn trong thai kỳ: Mức độ an toàn, diễn tiến lâm sàng và kinh nghiệm xử trí từ nghiên cứu bệnh-chứng https://news.medxy.ai/idiopathic-subglottic-stenosis-in-pregnancy-safety-clinical-course-and-management-insights-from-a-case-control-study/Medxy AIen2026-10-10T04:04:27-07:00Idiopathic Subglottic Stenosis in Pregnancy: Safety, Clinical Course, and Management Insights from a Case-Control Study https://news.medxy.ai/zh/thyroid-parathyroid-pneumothorax/Medxy AIzh2026-10-10T04:03:47-07:00甲状腺与甲状旁腺手术后气胸：少见却高风险 https://news.medxy.ai/ja/rare-thoracic-complication/Medxy AIja2026-10-10T04:03:31-07:00見逃せない稀な合併症：甲状腺・副甲状腺手術後気胸の臨床的意義 https://news.medxy.ai/vi/pneumothorax-after-thyroid-surgery/Medxy AIvi2026-10-10T04:03:14-07:00Hiếm nhưng nguy hiểm: Ý nghĩa lâm sàng của tràn khí màng phổi sau cắt tuyến giáp và tuyến cận giáp https://news.medxy.ai/rare-but-risky-clinical-implications-of-pneumothorax-following-thyroidectomy-and-parathyroidectomy/Medxy AIen2026-10-10T04:02:58-07:00Rare But Risky: Clinical Implications of Pneumothorax Following Thyroidectomy and Parathyroidectomy https://news.medxy.ai/zh/surgical-pathway-shift/Medxy AIzh2026-10-10T04:02:22-07:00手术路径的转变：某科室由全扁桃体切除术迈向囊内扁桃体切除术的经验与启示 https://news.medxy.ai/ja/tonsillectomy-shift/Medxy AIja2026-10-10T04:02:06-07:00扁桃摘出術の転換を読み解く：全摘から被膜内へ移行した診療科の知見 https://news.medxy.ai/vi/tonsillectomy-transition-key-factors/Medxy AIvi2026-10-10T04:01:45-07:00Từ cắt amidan toàn bộ đến cắt amidan trong bao: Những yếu tố then chốt trong quá trình chuyển đổi của một khoa https://news.medxy.ai/navigating-the-shift-insights-into-a-departments-transition-from-total-to-intracapsular-tonsillectomy/Medxy AIen2026-10-10T04:01:27-07:00Navigating the Shift: Insights into a Department’s Transition from Total to Intracapsular Tonsillectomy https://news.medxy.ai/zh/post-pancreatectomy-bleeding/Medxy AIzh2026-10-10T04:00:40-07:00揭开胰腺切除术后出血的面纱：基于大样本队列分析的出血来源、隐源性事件及严重程度预测因素 https://news.medxy.ai/ja/post-pancreatectomy-bleeding-3/Medxy AIja2026-10-10T04:00:22-07:00膵切除後出血の実像を読み解く：大規模コホートが示した出血源、原因不明例、重症化予測因子 https://news.medxy.ai/vi/post-pancreatectomy-bleeding-2/Medxy AIvi2026-10-10T04:00:00-07:00Làm rõ xuất huyết sau cắt tụy: nguồn chảy máu, biến cố vô căn và các yếu tố dự báo mức độ nặng từ phân tích một đoàn hệ lớn https://news.medxy.ai/unveiling-postpancreatectomy-hemorrhage-bleeding-sources-cryptogenic-events-and-predictors-of-severity-from-a-large-cohort-analysis/Medxy AIen2026-10-10T03:59:38-07:00Unveiling Postpancreatectomy Hemorrhage: Bleeding Sources, Cryptogenic Events, and Predictors of Severity from a Large Cohort Analysis https://news.medxy.ai/zh/quantifying-surgeon-intuition/Medxy AIzh2026-10-10T03:59:00-07:00量化外科医生直觉：视觉模拟量表能否预测术后结局 https://news.medxy.ai/ja/82984-2/Medxy AIja2026-10-10T03:58:43-07:00外科医の直感を定量化する：視覚的アナログスケールは術後転帰を予測できるか https://news.medxy.ai/vi/surgeon-intuition-scale/Medxy AIvi2026-10-10T03:58:25-07:00Định lượng trực giác của phẫu thuật viên: Thang đo tương tự thị giác trong dự báo kết cục sau mổ https://news.medxy.ai/surgeon-intuition/Medxy AIen2026-10-10T03:58:08-07:00Quantifying the Surgeon’s Intuition: Visual Analog Scale as a Predictor of Postoperative Outcomes https://news.medxy.ai/zh/icg-liver-resection/Medxy AIzh2026-10-10T03:57:32-07:00吲哚菁绿荧光助力结直肠癌肝转移微创保肝切除：SICE Liver ICG研究解读 https://news.medxy.ai/ja/icg-liver-resection-2/Medxy AIja2026-10-10T03:57:15-07:00ICG蛍光で高める大腸癌肝転移に対する低侵襲肝切除の精度――SICE Liver ICG studyからの知見 https://news.medxy.ai/vi/liver-cutting-fluorescence/Medxy AIvi2026-10-10T03:56:55-07:00Nâng cao độ chính xác trong cắt gan ít xâm lấn đối với di căn đại trực tràng bằng huỳnh quang indocyanine green: Những phát hiện từ nghiên cứu SICE Liver ICG https://news.medxy.ai/enhancing-precision-in-minimally-invasive-liver-resection-for-colorectal-metastases-using-indocyanine-green-fluorescence-insights-from-the-sice-liver-icg-study/Medxy AIen2026-10-10T03:56:35-07:00Enhancing Precision in Minimally Invasive Liver Resection for Colorectal Metastases Using Indocyanine Green Fluorescence: Insights from the SICE Liver ICG Study https://news.medxy.ai/zh/multidisciplinary-survivorship-clinic/Medxy AIzh2026-10-10T03:55:55-07:00多学科晚期后遗症门诊在低位前切除综合征管理中的应用：一项前瞻性队列研究 https://news.medxy.ai/ja/lars-management/Medxy AIja2026-10-10T03:55:40-07:00直腸癌術後LARSの管理における多職種晩期後遺症外来：前向きコホート研究 https://news.medxy.ai/vi/post-rheumatic-complications/Medxy AIvi2026-10-10T03:55:24-07:00Phòng khám di chứng muộn đa chuyên khoa trong quản lý Hội chứng sau cắt trước thấp: Nghiên cứu đoàn hệ tiến cứu https://news.medxy.ai/multidisciplinary-late-sequelae-clinics-in-managing-low-anterior-resection-syndrome-a-prospective-cohort-study/Medxy AIen2026-10-10T03:55:08-07:00Multidisciplinary Late Sequelae Clinics in Managing Low Anterior Resection Syndrome: A Prospective Cohort Study https://news.medxy.ai/zh/82963-2/Medxy AIzh2026-10-10T03:54:33-07:00青少年腹股沟疝修补术后的长期慢性疼痛与性功能障碍：一项丹麦全国性调查的启示 https://news.medxy.ai/ja/82961-2/Medxy AIja2026-10-10T03:54:18-07:00思春期の鼠径ヘルニア修復術後の長期にわたる慢性疼痛および性機能障害：デンマークの全国調査からの知見 https://news.medxy.ai/vi/chronic-pain-sexual-dysfunction/Medxy AIvi2026-10-10T03:53:57-07:00Đau mạn tính kéo dài và rối loạn chức năng tình dục sau sửa thoát vị bẹn ở thanh thiếu niên: Góc nhìn từ khảo sát toàn quốc tại Đan Mạch https://news.medxy.ai/long-term-chronic-pain-and-sexual-dysfunction-after-adolescent-groin-hernia-repair-insights-from-a-danish-nationwide-survey/Medxy AIen2026-10-10T03:53:40-07:00Long-Term Chronic Pain and Sexual Dysfunction After Adolescent Groin Hernia Repair: Insights from a Danish Nationwide Survey https://news.medxy.ai/zh/closing-gun-law-gap/Medxy AIzh2026-10-10T03:53:01-07:00弥补枪支立法缺口：减少美国11万例可预防的枪支自杀死亡 https://news.medxy.ai/ja/gun-law-gap/Medxy AIja2026-10-10T03:52:46-07:00銃器規制の法的空白を埋める：全米で回避可能な11万件の銃器自殺を減らすために https://news.medxy.ai/vi/gun-law-gaps/Medxy AIvi2026-10-10T03:52:27-07:00Lấp đầy khoảng trống pháp luật về súng: giảm 110.000 ca tự sát bằng súng có thể phòng tránh trên toàn nước Mỹ https://news.medxy.ai/bridging-the-firearm-law-gaps-reducing-110000-preventable-firearm-suicides-across-the-u-s/Medxy AIen2026-10-10T03:52:10-07:00Bridging the Firearm Law Gaps: Reducing 110,000 Preventable Firearm Suicides Across the U.S. https://news.medxy.ai/zh/farletuzumab-eceteribulin/Medxy AIzh2026-10-10T03:51:02-07:00Farletuzumab Ecteribulin：在靶向叶酸受体α的同时优化给药，以降低晚期癌症中的肺毒性 https://news.medxy.ai/ja/farletuzumab-optimization/Medxy AIja2026-10-10T03:50:45-07:00Farletuzumab ecteribulin：進行がんにおけるFRα標的化と肺毒性軽減を両立する投与最適化 https://news.medxy.ai/vi/farletuzumab-eceteribulin-dose-optimization/Medxy AIvi2026-10-10T03:50:25-07:00Farletuzumab Ecteribulin: Tối ưu hóa liều để giảm độc tính phổi khi nhắm vào folate receptor alpha trong các ung thư tiến triển https://news.medxy.ai/farletuzumab-ecteribulin-optimizing-dosing-to-mitigate-lung-toxicity-while-targeting-folate-receptor-alpha-in-advanced-cancers/Medxy AIen2026-10-10T03:50:07-07:00Farletuzumab Ecteribulin: Optimizing Dosing to Mitigate Lung Toxicity While Targeting Folate Receptor Alpha in Advanced Cancers https://news.medxy.ai/zh/bridging-menopause-knowledge-gap/Medxy AIzh2026-10-10T03:49:29-07:00弥合知识缺口：提升临床医生的绝经教育 https://news.medxy.ai/ja/menopause-education-gap/Medxy AIja2026-10-10T03:49:15-07:00閉経教育の格差を埋める：臨床医のための学習強化 https://news.medxy.ai/vi/82930-2/Medxy AIvi2026-10-10T03:48:59-07:00Thu hẹp khoảng cách trong giáo dục về mãn kinh: Tăng cường đào tạo cho bác sĩ lâm sàng https://news.medxy.ai/bridging-the-knowledge-gap-enhancing-menopause-education-for-clinicians/Medxy AIen2026-10-10T03:48:42-07:00Bridging the Knowledge Gap: Enhancing Menopause Education for Clinicians https://news.medxy.ai/zh/endometrial-cancer-race-ethnicity/Medxy AIzh2026-10-10T03:48:05-07:00子宫内膜癌治疗启动与生存的种族及族裔差异：社会经济调节因素与临床启示 https://news.medxy.ai/ja/endometrial-cancer-disparities/Medxy AIja2026-10-10T03:47:44-07:00子宮内膜癌における治療開始と生存の人種・民族格差：社会経済的修飾因子と臨床的含意 https://news.medxy.ai/vi/racial-ethnic-disparities-cancer/Medxy AIvi2026-10-10T03:47:19-07:00Chênh lệch chủng tộc và sắc tộc trong khởi trị điều trị và sống còn ở bệnh nhân ung thư nội mạc tử cung: Vai trò của các yếu tố kinh tế – xã hội và hàm ý lâm sàng https://news.medxy.ai/racial-and-ethnic-disparities-in-treatment-initiation-and-survival-among-patients-with-endometrial-cancer-socioeconomic-modifiers-and-clinical-implications/Medxy AIen2026-10-10T03:46:58-07:00Racial and Ethnic Disparities in Treatment Initiation and Survival Among Patients With Endometrial Cancer: Socioeconomic Modifiers and Clinical Implications https://news.medxy.ai/zh/masld-risk-regulation/Medxy AIzh2026-10-10T03:46:11-07:00PNPLA3I148M 携带者 MASLD 风险的调控：肠道菌群与神经酰胺的作用 https://news.medxy.ai/ja/pnpla3-masld-risk/Medxy AIja2026-10-10T03:45:55-07:00PNPLA3I148M保有者のMASLDリスクをどう制御するか：腸内細菌叢とセラミドの役割 https://news.medxy.ai/vi/masld-risk-pnpla3/Medxy AIvi2026-10-10T03:45:36-07:00Điều biến nguy cơ MASLD ở người mang PNPLA3I148M: Vai trò của hệ vi sinh đường ruột và ceramide https://news.medxy.ai/modulating-masld-risk-in-pnpla3i148m-carriers-the-role-of-gut-microbiota-and-ceramides/Medxy AIen2026-10-10T03:45:18-07:00Modulating MASLD Risk in PNPLA3I148M Carriers: The Role of Gut Microbiota and Ceramides https://news.medxy.ai/zh/82917-2/Medxy AIzh2026-10-10T03:44:39-07:00解析化疗诱导的周围神经毒性风险：持续性及剂量限制性神经毒性的临床预测指标 https://news.medxy.ai/ja/chemotherapy-neurotoxicity/Medxy AIja2026-10-10T03:44:20-07:00化学療法誘発末梢神経毒性を読み解く：用量制限性および持続性神経毒性を左右する臨床予測因子 https://news.medxy.ai/vi/82913-2/Medxy AIvi2026-10-10T03:43:58-07:00Giải mã các nguy cơ gây độc thần kinh ngoại biên do hóa trị: Các yếu tố lâm sàng dự báo độc tính thần kinh dai dẳng và độc tính giới hạn liều https://news.medxy.ai/decoding-risks-of-chemotherapy-induced-peripheral-neurotoxicity-clinical-predictors-of-dose-limiting-and-persistent-neurologic-toxicity/Medxy AIen2026-10-10T03:43:38-07:00Decoding Risks of Chemotherapy-Induced Peripheral Neurotoxicity: Clinical Predictors of Dose-Limiting and Persistent Neurologic Toxicity https://news.medxy.ai/zh/82907-2/Medxy AIzh2026-10-10T03:42:52-07:00心脏骤停后超难治性癫痫持续状态的双重抗谷氨酸治疗：基于 SUPER-CAT 研究及现有证据的见解 https://news.medxy.ai/ja/super-cat-epilepsy-treatment/Medxy AIja2026-10-10T03:42:32-07:00心停止後の超難治性てんかん重積状態に対する二重抗グルタミン酸療法：SUPER-CAT研究と最新エビデンスからの示唆 https://news.medxy.ai/vi/dual-glutamate-therapy/Medxy AIvi2026-10-10T03:42:07-07:00Liệu pháp kháng glutamate kép trong trạng thái động kinh kháng trị siêu nặng sau ngừng tim: Góc nhìn từ nghiên cứu SUPER-CAT và bằng chứng hiện có https://news.medxy.ai/dual-antiglutamate-therapy-in-super-refractory-status-epilepticus-after-cardiac-arrest-insights-from-the-super-cat-study-and-current-evidence/Medxy AIen2026-10-10T03:41:43-07:00Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest: Insights from the SUPER-CAT Study and Current Evidence https://news.medxy.ai/zh/82898-2/Medxy AIzh2026-10-10T03:40:51-07:00阿尔茨海默病中血浆 pTau217（Lumipulse G 检测）与颞叶皮层病理改变之间的定量关系 https://news.medxy.ai/ja/82896-2/Medxy AIja2026-10-10T03:40:32-07:00アルツハイマー病における血漿中pTau217のLumipulse G測定値と側頭葉皮質の病理学的変化との量的関係 https://news.medxy.ai/vi/ptau217-alzheimer-link/Medxy AIvi2026-10-10T03:40:07-07:00Mối liên hệ định lượng giữa pTau217 đo bằng Lumipulse G trong huyết tương và bệnh lý vỏ não thái dương trong bệnh Alzheimer https://news.medxy.ai/quantitative-relationship-between-lumipulse-g-measures-of-ptau217-in-plasma-and-temporal-cortex-pathology-in-alzheimer-disease/Medxy AIen2026-10-10T03:39:46-07:00Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and Temporal Cortex Pathology in Alzheimer Disease https://news.medxy.ai/zh/ocrelizumab-ms-insights/Medxy AIzh2026-10-10T03:38:54-07:00复发型多发性硬化中奥瑞珠单抗10年治疗的启示：来自OPERA I和II随机临床试验及相关证据 https://news.medxy.ai/ja/ocrelizumab-ms-10years/Medxy AIja2026-10-10T03:38:34-07:00再発型多発性硬化症におけるオクリズマブ10年の軌跡：OPERA I・II無作為化臨床試験と関連エビデンスからの知見 https://news.medxy.ai/vi/ocrelizumab-ms-trials/Medxy AIvi2026-10-10T03:38:12-07:00Ocrelizumab trong bệnh đa xơ cứng tái phát sau 10 năm: Những phát hiện từ các thử nghiệm lâm sàng ngẫu nhiên OPERA I và II và bằng chứng liên quan https://news.medxy.ai/ten-years-of-ocrelizumab-in-relapsing-multiple-sclerosis-insights-from-the-opera-i-and-ii-randomized-clinical-trials-and-related-evidence/Medxy AIen2026-10-10T03:37:51-07:00Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: Insights from the OPERA I and II Randomized Clinical Trials and Related Evidence https://news.medxy.ai/ja/vascular-imaging-guidelines/Medxy AIja2026-10-10T03:36:55-07:00カテ室の好奇心からガイドラインの必須項目へ：血管内イメージングはいかに複雑PCIの要となったか https://news.medxy.ai/vi/pci-imaging/Medxy AIvi2026-10-10T03:36:24-07:00Từ tò mò trong phòng thông tim đến yêu cầu bắt buộc của hướng dẫn: vì sao chẩn đoán hình ảnh trong lòng mạch trở thành trụ cột của PCI phức tạp https://news.medxy.ai/zh/intravascular-imaging-core/Medxy AIzh2026-10-10T03:35:56-07:00从导管室的新奇工具到指南硬性要求：血管内影像如何成为复杂PCI的核心 https://news.medxy.ai/from-cath-lab-curiosity-to-guideline-mandate-how-intravascular-imaging-became-essential-for-complex-pci/Medxy AIen2026-10-10T03:35:29-07:00From Cath Lab Curiosity to Guideline Mandate: How Intravascular Imaging Became Essential for Complex PCI https://news.medxy.ai/zh/conduction-pacing-vs-biventricular/Medxy AIzh2026-10-10T03:34:16-07:00房室结消融后：传导系统起搏与双心室起搏谁更优？CONDUCT-AF试验带来新启示 https://news.medxy.ai/ja/av-nodal-ablation-pacing/Medxy AIja2026-10-10T03:33:58-07:00心不全合併心房細動におけるAV結節アブレーション後の伝導系ペーシングと両心室ペーシング：CONDUCT-AF試験が示した知見 https://news.medxy.ai/vi/biventricular-pacing-after-av-node-ablation/Medxy AIvi2026-10-10T03:33:34-07:00Tạo nhịp hệ dẫn truyền tim hay tạo nhịp hai thất sau triệt phá nút AV ở rung nhĩ kèm suy tim: Góc nhìn từ thử nghiệm CONDUCT-AF https://news.medxy.ai/conduction-system-pacing-vs-biventricular-pacing-after-av-node-ablation-in-af-with-heart-failure-insights-from-the-conduct-af-trial/Medxy AIen2026-10-10T03:33:16-07:00Conduction System Pacing vs Biventricular Pacing After AV Node Ablation in AF with Heart Failure: Insights from the CONDUCT-AF Trial https://news.medxy.ai/zh/adult-congenital-heart-disease-3/Medxy AIzh2026-10-10T03:32:36-07:00成年先天性心脏病患者：获得性心血管危险因素如何影响长期生存 https://news.medxy.ai/ja/congenital-heart-disease-risk/Medxy AIja2026-10-10T03:32:21-07:00成人先天性心疾患における後天性心血管リスク因子が長期生存に及ぼす影響 https://news.medxy.ai/vi/adult-congenital-heart-disease-4/Medxy AIvi2026-10-10T03:32:04-07:00Người lớn mắc bệnh tim bẩm sinh: Hé lộ tác động của các yếu tố nguy cơ tim mạch mắc phải lên sống còn lâu dài https://news.medxy.ai/adults-with-congenital-heart-disease-unveiling-the-impact-of-acquired-cardiovascular-risk-factors-on-long-term-survival/Medxy AIen2026-10-10T03:31:44-07:00Adults with Congenital Heart Disease: Unveiling the Impact of Acquired Cardiovascular Risk Factors on Long-Term Survival https://news.medxy.ai/zh/in-hospital-cardiac-arrest/Medxy AIzh2026-10-10T03:31:09-07:00中国院内心搏骤停：一项多中心前瞻性研究揭示发生率、救治过程与生存结局 https://news.medxy.ai/ja/in-hospital-cardiac-arrest-japan/Medxy AIja2026-10-10T03:30:55-07:00中国における院内心停止：多施設前向き研究が示した発生率・ケア過程・生存転帰 https://news.medxy.ai/vi/in-hospital-cardiac-arrest-china/Medxy AIvi2026-10-10T03:30:34-07:00Ngừng tim trong bệnh viện tại Trung Quốc: Tỷ lệ mắc, quy trình chăm sóc và kết cục sống sót trong một nghiên cứu tiến cứu đa trung tâm https://news.medxy.ai/in-hospital-cardiac-arrest-in-china-incidence-care-processes-and-survival-outcomes-in-a-multicenter-prospective-study/Medxy AIen2026-10-10T03:30:16-07:00In-Hospital Cardiac Arrest in China: Incidence, Care Processes, and Survival Outcomes in a Multicenter Prospective Study https://news.medxy.ai/zh/pgpc-npc1-syntaxin17-autophagy/Medxy AIzh2026-10-10T03:29:34-07:00氧化磷脂PGPC通过NPC1介导的syntaxin 17修饰破坏内皮自噬，抑制血管生成 https://news.medxy.ai/ja/pgpc-npc1-autophagy-angiogenesis/Medxy AIja2026-10-10T03:29:17-07:00酸化リン脂質PGPCがNPC1依存的にsyntaxin 17を修飾し、内皮オートファジー障害を介して血管新生を抑制 https://news.medxy.ai/vi/82840-2/Medxy AIvi2026-10-10T03:28:57-07:00Phospholipid bị oxy hóa PGPC làm gián đoạn quá trình tự thực của tế bào nội mô và ức chế sự hình thành mạch máu thông qua việc biến đổi syntaxin 17 do NPC1 điều hòa https://news.medxy.ai/oxidized-phospholipid-pgpc-impedes-angiogenesis-by-disrupting-endothelial-autophagy-via-npc1-mediated-syntaxin-17-modification/Medxy AIen2026-10-10T03:28:38-07:00Oxidized Phospholipid PGPC Impedes Angiogenesis by Disrupting Endothelial Autophagy via NPC1-Mediated Syntaxin 17 Modification https://news.medxy.ai/zh/82835-2/Medxy AIzh2026-10-10T03:27:57-07:00PREVENT试验分析显示脂质核心负荷指数可识别能从预防性PCI中获益的易损斑块 https://news.medxy.ai/ja/coronary-intervention-optimization/Medxy AIja2026-10-10T03:27:37-07:00冠動脈インターベンション最適化：脂質コア負荷指数がPREVENT試験解析で予防的PCIの恩恵を受ける脆弱プラークを同定 https://news.medxy.ai/vi/82833-2/Medxy AIvi2026-10-10T03:27:17-07:00Tối ưu hóa can thiệp mạch vành: Chỉ số gánh nặng lõi lipid giúp xác định các mảng xơ vữa dễ vỡ hưởng lợi từ can thiệp mạch vành qua da (PCI) dự phòng trong phân tích thử nghiệm PREVENT https://news.medxy.ai/optimizing-coronary-intervention-lipid-core-burden-index-identifies-vulnerable-plaques-benefiting-from-preventive-pci-in-prevent-trial-analysis/Medxy AIen2026-10-10T03:26:58-07:00Optimizing Coronary Intervention: Lipid Core Burden Index Identifies Vulnerable Plaques Benefiting from Preventive PCI in PREVENT Trial Analysis https://news.medxy.ai/zh/reduce-delayed-gastric-emptying/Medxy AIzh2026-10-10T03:24:02-07:00胰十二指肠切除术后如何降低延迟性胃排空？侧侧与端侧胃空肠吻合的随机试验结果 https://news.medxy.ai/ja/gastrectomy-anastomosis-comparison-2/Medxy AIja2026-10-10T03:23:46-07:00膵頭十二指腸切除後の遅延胃排出を減らすのはどちらか：側側胃空腸吻合と端側胃空腸吻合をIPAD無作為化試験から検証 https://news.medxy.ai/vi/gastric-emptying-comparison/Medxy AIvi2026-10-10T03:23:26-07:00So sánh nối dạ dày – hỗng tràng bên – bên và tận – bên trong giảm chậm làm rỗng dạ dày sau phẫu thuật cắt tá tụy: Góc nhìn từ thử nghiệm ngẫu nhiên IPAD https://news.medxy.ai/comparing-side-to-side-and-end-to-side-gastrojejunostomy-for-reducing-delayed-gastric-emptying-after-pancreatoduodenectomy-insights-from-the-ipad-randomized-trial/Medxy AIen2026-10-10T03:23:07-07:00Comparing Side-to-Side and End-to-Side Gastrojejunostomy for Reducing Delayed Gastric Emptying After Pancreatoduodenectomy: Insights from the IPAD Randomized Trial https://news.medxy.ai/zh/fgf18-fgfr3-leukemia/Medxy AIzh2026-10-09T04:35:03-07:00瞄准 FGF18-FGFR3 轴：急性髓系白血病治疗的新前沿 https://news.medxy.ai/ja/fgf18-fgfr3-leukemia-treatment/Medxy AIja2026-10-09T04:34:48-07:00FGF18-FGFR3軸を標的とした急性骨髄性白血病治療の新たな展開 https://news.medxy.ai/vi/fgf18-fgfr3-target/Medxy AIvi2026-10-09T04:34:29-07:00Nhắm trúng trục FGF18-FGFR3: Hướng đi mới trong điều trị bệnh bạch cầu tủy cấp https://news.medxy.ai/targeting-the-fgf18-fgfr3-axis-a-new-frontier-in-acute-myeloid-leukemia-therapy/Medxy AIen2026-10-09T04:34:10-07:00Targeting the FGF18-FGFR3 Axis: A New Frontier in Acute Myeloid Leukemia Therapy https://news.medxy.ai/zh/aav-factor-viii-activation-2/Medxy AIzh2026-10-09T04:33:32-07:00一期法揭示AAV来源凝血因子VIII凝血酶激活增强：对血友病A基因治疗的启示 https://news.medxy.ai/ja/aav-factor-viii-activation/Medxy AIja2026-10-09T04:33:15-07:00AAV由来第VIII因子のトロンビン活性化亢進を一段階凝固検査で検出：血友病A遺伝子治療への示唆 https://news.medxy.ai/vi/aav-fviii-thrombin-activation/Medxy AIvi2026-10-09T04:32:57-07:00Xét nghiệm một giai đoạn cho thấy AAV-FVIII hoạt hóa thrombin mạnh hơn: Hàm ý đối với liệu pháp gen hemophilia A https://news.medxy.ai/one-stage-assay-reveals-enhanced-thrombin-activation-by-aav-derived-factor-viii-implications-for-hemophilia-a-gene-therapy/Medxy AIen2026-10-09T04:32:39-07:00One-stage Assay Reveals Enhanced Thrombin Activation by AAV-Derived Factor VIII: Implications for Hemophilia A Gene Therapy https://news.medxy.ai/zh/antifibrotic-dose-adjustment/Medxy AIzh2026-10-09T04:31:59-07:00抗纤维化药物剂量调整对特发性肺纤维化结局的影响：来自真实世界数据的启示 https://news.medxy.ai/ja/dose-adjustment-antifibrotics/Medxy AIja2026-10-09T04:31:42-07:00抗線維化薬の用量調整は特発性肺線維症の転帰にどう影響するのか：リアルワールドデータからの知見 https://news.medxy.ai/impact-of-antifibrotic-dose-modifications-on-idiopathic-pulmonary-fibrosis-outcomes-insights-from-real-world-data/Medxy AIen2026-10-09T04:31:06-07:00Impact of Antifibrotic Dose Modifications on Idiopathic Pulmonary Fibrosis Outcomes: Insights from Real-World Data https://news.medxy.ai/zh/cystic-fibrosis-aspergillosis-treatment/Medxy AIzh2026-10-09T04:30:30-07:00囊性纤维化合并过敏性支气管肺曲霉病：口服糖皮质激素与抗真菌治疗的真实世界疗效对比 https://news.medxy.ai/ja/cf-abpa-treatment-comparison/Medxy AIja2026-10-09T04:30:12-07:00嚢胞性線維症合併ABPAに対する経口コルチコステロイドと抗真菌薬の実臨床効果の比較 https://news.medxy.ai/vi/oral-steroids-vs-antifungals/Medxy AIvi2026-10-09T04:29:54-07:00Corticosteroid đường uống hay thuốc kháng nấm: điều gì hiệu quả hơn trong ABPA ở bệnh nhân xơ nang? https://news.medxy.ai/real-world-effectiveness-of-oral-corticosteroids-versus-antifungals-in-allergic-bronchopulmonary-aspergillosis-among-cystic-fibrosis-patients/Medxy AIen2026-10-09T04:29:37-07:00Real-World Effectiveness of Oral Corticosteroids Versus Antifungals in Allergic Bronchopulmonary Aspergillosis Among Cystic Fibrosis Patients https://news.medxy.ai/zh/wbc-sepsis-antibiotics/Medxy AIzh2026-10-09T04:29:00-07:00白细胞计数能否预测脓毒症抗生素疗效？来自头孢吡肟与哌拉西林-他唑巴坦比较研究的启示 https://news.medxy.ai/ja/white-blood-cell-predictor/Medxy AIja2026-10-09T04:28:44-07:00敗血症における抗菌薬有効性の予測因子としての白血球数――セフェピムとピペラシリン・タゾバクタム比較研究からの示唆 https://news.medxy.ai/vi/white-blood-cells-antibiotics/Medxy AIvi2026-10-09T04:28:25-07:00Số lượng bạch cầu có dự đoán hiệu quả kháng sinh trong nhiễm trùng huyết? Bằng chứng từ các nghiên cứu so sánh cefepime và piperacillin-tazobactam https://news.medxy.ai/white-blood-cell-count-as-a-predictor-of-antibiotic-efficacy-in-sepsis-insights-from-comparative-studies-of-cefepime-and-piperacillin-tazobactam/Medxy AIen2026-10-09T04:28:07-07:00White Blood Cell Count as a Predictor of Antibiotic Efficacy in Sepsis: Insights from Comparative Studies of Cefepime and Piperacillin-Tazobactam https://news.medxy.ai/zh/occupational-dust-smoke-risks/Medxy AIzh2026-10-09T04:27:30-07:00职业性粉尘与烟雾暴露会增加吸烟者呼吸与心血管并发症风险 https://news.medxy.ai/ja/smoking-exposure-risk/Medxy AIja2026-10-09T04:27:14-07:00喫煙者における粉じん・ヒューム曝露、呼吸器および心血管合併症のリスクを上昇 https://news.medxy.ai/vi/82111-2/Medxy AIvi2026-10-09T04:26:55-07:00Việc tiếp xúc với bụi và khói bụi trong môi trường làm việc làm tăng nguy cơ gặp các biến chứng về hô hấp và tim mạch ở người hút thuốc https://news.medxy.ai/occupational-dust-and-fume-exposure-elevates-risk-of-respiratory-and-cardiovascular-complications-in-smokers/Medxy AIen2026-10-09T04:26:36-07:00Occupational Dust and Fume Exposure Elevates Risk of Respiratory and Cardiovascular Complications in Smokers https://news.medxy.ai/zh/abicipar-octa-treatment/Medxy AIzh2026-10-09T04:25:56-07:00基于纵向OCTA评估阿柏西普联合低能量光动力治疗在脉络膜息肉样血管病变中的疗效 https://news.medxy.ai/ja/aflibercept-pdt-pcv/Medxy AIja2026-10-09T04:25:39-07:00PCVにおけるアフリベルセプトと低照射量PDTの併用効果を検証：長期OCTA解析からみた所見 https://news.medxy.ai/evaluating-aflibercept-with-reduced-fluence-photodynamic-therapy-in-polypoidal-choroidal-vasculopathy-insights-from-longitudinal-oct-angiography/Medxy AIen2026-10-09T04:25:02-07:00Evaluating Aflibercept With Reduced-Fluence Photodynamic Therapy in Polypoidal Choroidal Vasculopathy: Insights from Longitudinal OCT Angiography https://news.medxy.ai/zh/wide-angle-oct-tumor-2/Medxy AIzh2026-10-09T04:24:26-07:00超广角扫频源OCT在脉络膜肿瘤评估中的应用：与超声、SD-OCT及MRI的比较分析 https://news.medxy.ai/ja/wide-angle-oct-tumor/Medxy AIja2026-10-09T04:24:09-07:00超広角掃引光源OCTで脈絡膜腫瘍評価を高精度化：超音波検査、SD-OCT、MRIとの比較解析 https://news.medxy.ai/vi/wide-field-oct-uveal-tumor/Medxy AIvi2026-10-09T04:23:50-07:00Nâng cao đánh giá u màng mạch nho bằng OCT nguồn quét diện trường siêu rộng: phân tích so sánh với siêu âm, SD-OCT và MRI https://news.medxy.ai/enhancing-choroidal-tumor-assessment-with-ultra-widefield-swept-source-oct-a-comparative-analysis-with-ultrasonography-sd-oct-and-mri/Medxy AIen2026-10-09T04:23:32-07:00Enhancing Choroidal Tumor Assessment with Ultra-Widefield Swept-Source OCT: A Comparative Analysis with Ultrasonography, SD-OCT, and MRI https://news.medxy.ai/zh/functional-rhinoplasty/Medxy AIzh2026-10-09T04:22:52-07:00功能性鼻整形术：从症状改善到长期生活质量提升 https://news.medxy.ai/ja/functional-rhinoplasty-qol/Medxy AIja2026-10-09T04:22:37-07:00機能的鼻形成術の疾患特異的改善が長期QOLに結び付く仕組み https://news.medxy.ai/vi/functional-rhinoplasty-benefits/Medxy AIvi2026-10-09T04:22:20-07:00Phẫu thuật tạo hình mũi chức năng: Liên hệ giữa cải thiện triệu chứng và chất lượng cuộc sống lâu dài https://news.medxy.ai/linking-disease-specific-gains-to-long-term-quality-of-life-in-functional-rhinoplasty/Medxy AIen2026-10-09T04:22:04-07:00Linking Disease-Specific Gains to Long-Term Quality of Life in Functional Rhinoplasty https://news.medxy.ai/zh/tracheal-surgery-comparison/Medxy AIzh2026-10-09T04:21:26-07:00滑行气管成形术与端端吻合术的力学差异：离体猪气管模型分析 https://news.medxy.ai/ja/tracheoplasty-mechanics/Medxy AIja2026-10-09T04:21:08-07:00スライド気管形成術と端々吻合の力学的差異：ex vivo豚気管モデルによる解析 https://news.medxy.ai/vi/tracheoplasty-analysis/Medxy AIvi2026-10-09T04:20:52-07:00Phân tích cơ học giữa slide tracheoplasty và nối tận – tận: nghiên cứu trên mô hình khí quản lợn ex vivo https://news.medxy.ai/mechanical-insights-into-slide-tracheoplasty-versus-end-to-end-anastomosis-an-ex-vivo-porcine-model-analysis/Medxy AIen2026-10-09T04:20:34-07:00Mechanical Insights into Slide Tracheoplasty Versus End-to-End Anastomosis: An Ex Vivo Porcine Model Analysis https://news.medxy.ai/zh/thyroid-surgery-parathyroid-preservation/Medxy AIzh2026-10-09T04:19:58-07:00全甲状腺切除中甲状旁腺保留的新视角：近红外自发荧光的长期随机试验结果 https://news.medxy.ai/ja/thyroid-surgery-fluorescence/Medxy AIja2026-10-09T04:19:41-07:00甲状腺全摘術における副甲状腺温存のための近赤外自家蛍光評価：前向き無作為化試験の長期成績 https://news.medxy.ai/vi/82065-2/Medxy AIvi2026-10-09T04:19:21-07:00Những quan điểm mới về việc bảo tồn tuyến cận giáp trong phẫu thuật cắt toàn bộ tuyến giáp https://news.medxy.ai/evaluating-near-infrared-autofluorescence-for-parathyroid-preservation-in-total-thyroidectomy-long-term-outcomes-from-a-prospective-randomized-trial/Medxy AIen2026-10-09T04:19:04-07:00Evaluating Near-Infrared Autofluorescence for Parathyroid Preservation in Total Thyroidectomy: Long-Term Outcomes from a Prospective Randomized Trial https://news.medxy.ai/zh/hernia-recurrence-age/Medxy AIzh2026-10-09T04:18:28-07:00原发性腹壁疝修补术后复发风险受年龄影响：对临床实践的启示 https://news.medxy.ai/ja/hernia-recurrence-age-2/Medxy AIja2026-10-09T04:18:11-07:00一次腹壁ヘルニア修復後の再発リスクは年齢で変わる：臨床実践への示唆 https://news.medxy.ai/vi/hernia-repair-risks/Medxy AIvi2026-10-09T04:17:53-07:00Nguy cơ tái phát sau sửa chữa thoát vị thành bụng nguyên phát thay đổi theo tuổi: ý nghĩa đối với thực hành lâm sàng https://news.medxy.ai/age-dependent-recurrence-risk-after-primary-ventral-hernia-repair-implications-for-clinical-practice/Medxy AIen2026-10-09T04:17:36-07:00Age-Dependent Recurrence Risk After Primary Ventral Hernia Repair: Implications for Clinical Practice https://news.medxy.ai/zh/wilms-tumor-prognosis/Medxy AIzh2026-10-09T04:17:01-07:00早期有利组织学型 Wilms 肿瘤中的年龄、肿瘤大小与体重：基于 COG 数据重新评估预后指标 https://news.medxy.ai/ja/wilms-tumor-prognosis-2/Medxy AIja2026-10-09T04:16:44-07:00早期良好組織型Wilms腫瘍における年齢・腫瘍サイズ・体重の意義：COGデータで予後指標を再評価する https://news.medxy.ai/vi/wilms-tumor-factors/Medxy AIvi2026-10-09T04:16:24-07:00Tuổi, kích thước khối u và trọng lượng trong u Wilms mô học thuận lợi giai đoạn sớm: Xem xét lại các chỉ dấu tiên lượng từ dữ liệu COG https://news.medxy.ai/age-tumor-size-and-weight-in-early-stage-favorable-histology-wilms-tumor-reevaluating-prognostic-indicators-with-cog-data/Medxy AIen2026-10-09T04:16:07-07:00Age, Tumor Size, and Weight in Early-Stage Favorable Histology Wilms Tumor: Reevaluating Prognostic Indicators with COG Data https://news.medxy.ai/zh/gastroduodenal-reconstruction/Medxy AIzh2026-10-09T03:33:48-07:00胰十二指肠切除术后胃空肠吻合方式如何选择：侧侧与端侧重建对延迟性胃排空的影响 https://news.medxy.ai/ja/gastrectomy-anastomosis-comparison/Medxy AIja2026-10-09T03:33:31-07:00膵頭十二指腸切除後の胃空腸吻合法を検証：側側吻合と端側吻合の比較と遅延胃排出への影響 https://news.medxy.ai/vi/pancreaticojejunostomy-comparison/Medxy AIvi2026-10-09T03:33:11-07:00So sánh các kỹ thuật nối vị – hỗng tràng trong phẫu thuật cắt tá tụy: nối bên – bên hay tận – bên và ảnh hưởng lên chậm làm rỗng dạ dày https://news.medxy.ai/evaluating-gastrojejunostomy-techniques-in-pancreatoduodenectomy-side-to-side-vs-end-to-side-approaches-and-impact-on-delayed-gastric-emptying/Medxy AIen2026-10-09T03:32:45-07:00Evaluating Gastrojejunostomy Techniques in Pancreatoduodenectomy: Side-to-Side vs End-to-Side Approaches and Impact on Delayed Gastric Emptying https://news.medxy.ai/zh/latina-fibroids-insights/Medxy AIzh2026-10-09T03:32:08-07:00拉丁裔女性子宫肌瘤：来自 ELLA 研究的环境、平滑肌瘤、拉丁裔女性与脂肪性洞见 https://news.medxy.ai/ja/latina-leiomyomas/Medxy AIja2026-10-09T03:31:51-07:00Latina 女性の子宮筋腫：Environment, Leiomyomas, Latinas, and Adiposity Study からの知見 https://news.medxy.ai/vi/uterine-fibroids-latinas/Medxy AIvi2026-10-09T03:31:30-07:00U xơ tử cung ở phụ nữ Latina: những phát hiện từ nghiên cứu Environment, Leiomyomas, Latinas, and Adiposity https://news.medxy.ai/uterine-fibroids-in-latinas-insights-from-the-environment-leiomyomas-latinas-and-adiposity-study/Medxy AIen2026-10-09T03:31:09-07:00Uterine Fibroids in Latinas: Insights from the Environment, Leiomyomas, Latinas, and Adiposity Study https://news.medxy.ai/zh/82025-2/Medxy AIzh2026-10-09T03:30:19-07:00多发性硬化症中上颈髓萎缩的解析：区分衰老与疾病的影响 https://news.medxy.ai/ja/82023-2/Medxy AIja2026-10-09T03:30:01-07:00多発性硬化症における上位頸髄萎縮の解明：加齢と疾患の影響の切り分け https://news.medxy.ai/vi/82022-2/Medxy AIvi2026-10-09T03:29:43-07:00Làm sáng tỏ tình trạng teo tủy sống cổ đoạn cao trong bệnh đa xơ cứng: Phân tách ảnh hưởng của lão hóa và bệnh lý https://news.medxy.ai/decoding-upper-cervical-cord-atrophy-in-multiple-sclerosis-separating-aging-from-disease-effects/Medxy AIen2026-10-09T03:29:24-07:00Decoding Upper Cervical Cord Atrophy in Multiple Sclerosis: Separating Aging from Disease Effects https://news.medxy.ai/zh/rapid-genome-sequencing-pediatrics/Medxy AIzh2026-10-09T03:28:42-07:00快速全基因组测序重塑儿科神经科住院诊疗：诊断与管理价值显著提升 https://news.medxy.ai/ja/82013-2/Medxy AIja2026-10-09T03:28:22-07:00小児神経診療の変革：入院患者の診断と管理における迅速全ゲノムシーケンシングの影響 https://news.medxy.ai/vi/pediatric-neurocare-genomics/Medxy AIvi2026-10-09T03:28:02-07:00Cách mạng hóa chăm sóc thần kinh nhi khoa: Tác động của giải trình tự toàn bộ bộ gen nhanh trong chẩn đoán và xử trí nội trú https://news.medxy.ai/transforming-pediatric-neurology-care-the-impact-of-rapid-whole-genome-sequencing-in-inpatient-diagnosis-and-management/Medxy AIen2026-10-09T03:27:43-07:00Transforming Pediatric Neurology Care: The Impact of Rapid Whole-Genome Sequencing in Inpatient Diagnosis and Management https://news.medxy.ai/zh/blood-biomarkers-cognitive-impairment/Medxy AIzh2026-10-09T03:27:03-07:00血液生物标志物提前披露：提升认知障碍诊断把握并优化临床管理的新证据 https://news.medxy.ai/ja/blood-biomarkers-dementia/Medxy AIja2026-10-09T03:26:41-07:00血液バイオマーカーの早期開示が認知症診断と臨床判断をどう変えるか：最新ランダム化試験のレビュー https://news.medxy.ai/vi/biomarker-detection/Medxy AIvi2026-10-09T03:26:21-07:00Công bố sớm dấu ấn sinh học trong máu giúp tăng độ chắc chắn chẩn đoán và hỗ trợ quản lý lâm sàng trong rối loạn nhận thức: Tổng quan về một thử nghiệm lâm sàng ngẫu nhiên gần đây https://news.medxy.ai/earlier-disclosure-of-blood-based-biomarkers-enhances-diagnostic-certainty-and-clinical-management-in-cognitive-disorders-a-review-of-a-recent-randomized-clinical-trial/Medxy AIen2026-10-09T03:26:01-07:00Earlier Disclosure of Blood-Based Biomarkers Enhances Diagnostic Certainty and Clinical Management in Cognitive Disorders: A Review of a Recent Randomized Clinical Trial https://news.medxy.ai/zh/diabetes-diagnosis-gap/Medxy AIzh2026-10-09T03:25:17-07:00实验室确诊糖尿病为何仍有“诊疗断层”？全国队列研究带来新启示 https://news.medxy.ai/ja/81999-2/Medxy AIja2026-10-09T03:25:02-07:00検査で糖尿病と確定診断されても、なお「診療の断絶」が生じるのはなぜか？ https://news.medxy.ai/vi/diabetes-care-gap/Medxy AIvi2026-10-09T03:24:44-07:00Thu hẹp khoảng cách giữa chẩn đoán và điều trị ở bệnh nhân đái tháo đường được xác nhận bằng xét nghiệm: Góc nhìn từ một nghiên cứu đoàn hệ toàn quốc https://news.medxy.ai/bridging-the-diagnostic-and-treatment-divide-in-laboratory-confirmed-diabetes-insights-from-a-national-cohort-study/Medxy AIen2026-10-09T03:24:26-07:00Bridging the Diagnostic and Treatment Divide in Laboratory-Confirmed Diabetes: Insights from a National Cohort Study https://news.medxy.ai/zh/eye-proton-therapy-effects/Medxy AIzh2026-10-09T03:16:39-07:00眼部质子治疗对葡萄膜黑色素瘤患者角膜基底下神经丛的长期影响 https://news.medxy.ai/ja/81977-2/Medxy AIja2026-10-09T03:16:21-07:00ぶどう膜悪性黒色腫患者における眼部陽子線治療が角膜上皮下神経叢に及ぼす長期的な影響 https://news.medxy.ai/vi/long-term-proton-therapy-impact/Medxy AIvi2026-10-09T03:16:00-07:00Tác động dài hạn của xạ trị proton mắt lên đám rối thần kinh dưới biểu mô giác mạc ở bệnh nhân u hắc tố màng bồ đào https://news.medxy.ai/longitudinal-effects-of-ocular-proton-therapy-on-the-corneal-subbasal-nerve-plexus-in-uveal-melanoma-patients/Medxy AIen2026-10-09T03:15:40-07:00Longitudinal Effects of Ocular Proton Therapy on the Corneal Subbasal Nerve Plexus in Uveal Melanoma Patients https://news.medxy.ai/zh/car-t-therapy-effects/Medxy AIzh2026-10-09T03:14:57-07:00克隆性造血与治疗前中性粒细胞减少症对血液系统恶性肿瘤CAR-T疗效和毒性的影响 https://news.medxy.ai/ja/car-t-therapy-blood-cancer/Medxy AIja2026-10-09T03:14:40-07:00血液悪性腫瘍におけるCAR-T細胞療法の成績に及ぼすクローン性造血と治療前好中球減少の影響 https://news.medxy.ai/vi/car-t-treatment-effects/Medxy AIvi2026-10-09T03:14:21-07:00Tạo máu dòng vô tính và giảm bạch cầu trung tính trước điều trị ảnh hưởng thế nào đến kết quả CAR-T ở các ác tính huyết học? https://news.medxy.ai/impact-of-clonal-hematopoiesis-and-pre-treatment-neutropenia-on-car-t-cell-therapy-outcomes-in-hematological-malignancies/Medxy AIen2026-10-09T03:14:03-07:00Impact of Clonal Hematopoiesis and Pre-treatment Neutropenia on CAR-T Cell Therapy Outcomes in Hematological Malignancies https://news.medxy.ai/zh/bcell-lymphoma-treatment/Medxy AIzh2026-10-09T03:13:27-07:00大B细胞淋巴瘤一线治疗的复杂性如何破局：迈向统一的试验设计 https://news.medxy.ai/ja/b-cell-lymphoma-treatment/Medxy AIja2026-10-09T03:13:07-07:00大B細胞リンパ腫における治療の複雑性を読み解く：一次治療試験デザインの標準化に向けて https://news.medxy.ai/vi/large-b-cell-lymphoma/Medxy AIvi2026-10-09T03:12:43-07:00U lympho tế bào B lớn: Giảm độ phức tạp điều trị và hướng tới thiết kế thử nghiệm hàng đầu tiên hài hòa https://news.medxy.ai/navigating-the-therapeutic-complexity-in-large-b-cell-lymphoma-toward-harmonized-first-line-trial-designs/Medxy AIen2026-10-09T03:12:23-07:00Navigating the Therapeutic Complexity in Large B-Cell Lymphoma: Toward Harmonized First-Line Trial Designs https://news.medxy.ai/zh/elder-care-challenges/Medxy AIzh2026-10-09T02:42:23-07:00居家护理员照护老年人：工作挑战与福祉提升之道 https://news.medxy.ai/ja/overcoming-home-care-challenges/Medxy AIja2026-10-09T02:42:05-07:00在宅医療補助者の職場課題を乗り越え、ウェルビーイングを高めるために https://news.medxy.ai/vi/workplace-healthcare-caregivers/Medxy AIvi2026-10-09T02:41:46-07:00Vượt qua thách thức nơi làm việc và nâng cao sức khỏe cho nhân viên trợ giúp chăm sóc sức khỏe tại nhà khi chăm sóc người cao tuổi https://news.medxy.ai/navigating-workplace-challenges-and-enhancing-well-being-among-home-health-aides-caring-for-older-adults/Medxy AIen2026-10-09T02:41:23-07:00Navigating Workplace Challenges and Enhancing Well-being Among Home Health Aides Caring for Older Adults https://news.medxy.ai/zh/equitable-home-hospital/Medxy AIzh2026-10-09T02:40:44-07:00推动居家医院项目的公平发展：关于可及性、入组与价值的领导层见解 https://news.medxy.ai/ja/hospital-at-home-equity/Medxy AIja2026-10-09T02:40:25-07:00Hospital at Homeプログラムにおける公平性の前進：アクセス、登録、価値をめぐるリーダーの示唆 https://news.medxy.ai/vi/hospital-at-home-equity-2/Medxy AIvi2026-10-09T02:40:02-07:00Thúc đẩy công bằng trong chương trình Hospital at Home: Góc nhìn lãnh đạo về khả năng tiếp cận, tuyển chọn và giá trị https://news.medxy.ai/advancing-equity-in-hospital-at-home-programs-leadership-insights-on-access-enrollment-and-value/Medxy AIen2026-10-09T02:39:39-07:00Advancing Equity in Hospital at Home Programs: Leadership Insights on Access, Enrollment, and Value https://news.medxy.ai/zh/prostate-cancer-screening-benefits/Medxy AIzh2026-10-09T02:39:00-07:00让前列腺癌筛查更贴近获益：来自VA与Medicare实践的启示 https://news.medxy.ai/ja/prostate-cancer-screening-3/Medxy AIja2026-10-09T02:38:38-07:00患者利益に沿った前立腺がんスクリーニングへ：VAとMedicareの実践から見える示唆 https://news.medxy.ai/vi/prostate-cancer-screening-2/Medxy AIvi2026-10-09T02:38:15-07:00Tầm soát ung thư tuyến tiền liệt phù hợp hơn với lợi ích bệnh nhân: Góc nhìn từ thực hành VA và Medicare https://news.medxy.ai/aligning-prostate-cancer-screening-with-patient-benefit-insights-from-va-and-medicare-practices/Medxy AIen2026-10-09T02:37:53-07:00Aligning Prostate Cancer Screening with Patient Benefit: Insights from VA and Medicare Practices https://news.medxy.ai/ja/fasting-duration-effects/Medxy AIja2026-10-09T02:37:12-07:00採血前絶食の長さは検査結果にどこまで影響するか https://news.medxy.ai/vi/fasting-time-differences-tests/Medxy AIvi2026-10-09T02:36:50-07:00Thời gian nhịn ăn và sự khác biệt giữa các xét nghiệm xét nghiệm thường quy https://news.medxy.ai/fasting-duration-and-differences-across-routine-laboratory-tests/Medxy AIen2026-10-09T02:36:30-07:00Fasting Duration and Differences Across Routine Laboratory Tests